|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
2 Tower Pl, South San Francisco, California 94080, US
|
|
Initial Therapeutics is discovering and developing a new class of small-molecule medicines designed to halt pathogenic protein formation in the earliest stages.
Initial’s approach is unique and starkly differentiated from protein degradation and other interventions that recognize and tackle proteins only after they have been fully formed.
|
Initial Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Initial Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Initial Therapeutics customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.